Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

NCT07317544 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

227

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia (AGA)
Healthy Volunteers - Male and Female

Interventions

DRUG: ABS-201 IV Single Dose
DRUG: Placebo IV
DRUG: ABS-201 SC Multiple Doses
DRUG: Placebo SC Injection

Sponsor

Absci Pty Ltd.